Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06538285 · ClinicalTrials.gov registry record · Phase 2
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
A Phase 2 study of Methamphetamine Use Disorder, sponsored by Nicky Mehtani, MD, MPH.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06538285 is a Phase 2 study of Methamphetamine Use Disorder that is actively recruiting participants, run by Nicky Mehtani, MD, MPH. The registered enrollment target is 12 participants, below the 54-participant average among 12 other Methamphetamine Use Disorder trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06538285, a Phase 2 study of Methamphetamine Use Disorder, is actively recruiting participants, sponsored by Nicky Mehtani, MD, MPH.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn whether it is possible to use intramuscular (IM) ketamine in combination with psychotherapy to treat moderate-to-severe methamphetamine use disorder (MeUD) in publicly insured patients with or at-risk for HIV disease. The main questions it aims to answer are: * Do publicly insured patients find ketamine-assisted psychotherapy feasible and acceptable as a potential treatment for MeUD? * Is IM ketamine safe and tolerable among patients with MeUD? Participants will: * Receive 3 monitored doses of IM ketamine * Have 3 preparation and 4 integration psychotherapy visits * Report their daily amounts of methamphetamine used prior to, during, and up to 3 months following the intervention
Conditions Studied
Interventions
- DRUG Ketamine
- BEHAVIORAL Psychotherapy
Study Locations (1)
California
- San Francisco Department of Public Health - San Francicso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-03-04 |
| Est. Completion | 2026-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06538285
The ClinicalTrials.gov registry entry for NCT06538285 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 54-participant average among 12 other Methamphetamine Use Disorder trials with a reported enrollment target (78% lower). The listed sponsor is Nicky Mehtani, MD, MPH, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Methamphetamine Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.
NCT06538285 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06538285 about?
NCT06538285 is a clinical study titled "Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV". The goal of this clinical trial is to learn whether it is possible to use intramuscular (IM) ketamine in combination with psychotherapy to treat moderate-to-severe methamphetamine use disorder (MeUD) in publicly insured patients with or at-risk for HIV disease. The main questions it aims to answer a...
What is the current status of trial NCT06538285?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2025-03-04. Estimated completion is 2026-06.
What conditions does trial NCT06538285 study?
This clinical trial studies the following conditions: Methamphetamine Use Disorder.
What interventions are being tested in trial NCT06538285?
The interventions under investigation include: Ketamine (DRUG), Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06538285?
This trial is sponsored by Nicky Mehtani, MD, MPH, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06538285 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tirzepatide for Obesity and Meth Use Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM
COMPLETED · Phase 2
-
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
RECRUITING · NA
-
Deep TMS of Neural Circuits Associated With Stimulant Use Disorder
RECRUITING · NA
-
Non-Abstinence Outcomes in Methamphetamine Use Disorder
RECRUITING · NA
-
Methamphetamine and Troriluzole
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.